OLD LINE CAPITAL INVESTS IN CARRTECH
OLD LINE CAPITAL INVESTS IN CARRTECH
Old Line Capital Partners announced that they have made a significant investment in CarrTech LLC, to extend product development, sales, and marketing of CarrTech’s innovative filter needle.
CarrTech’s FROG® device (Filter Removal of Glass) saves lives, prevents injury, and saves time in the emergency room and anywhere glass ampoules are used for injectable medicine. FROG turns a multi-step operation into an all-in-one device, by combining a filter needle and a hypodermic needle into a single unit.
CarrTech has clearly built “a better mouse trap”, stated Jerry Schepers, Old Line Capital’s General Partner and Deal Lead for the CarrTech investment. “This is exactly the type of innovative technology we look for at Old Line Capital.”
“We are incredibly excited to have Old Line Capital as our lead investor,” said Sue Carr, President and Founder of CarrTech. “Old Line Capital personifies the diligence and professionalism of the very best Venture Capitalists. They provide the wisdom, experience, and relationships necessary to put FROG in the hands of doctors, nurses, and first responders world-wide.”
